NordICC trial doesn’t change the value of colonoscopy

Despite some sensational headlines following the publication of NordICC trial data in The New England Journal of Medicine, it’s important to understand that this study does not change the value of colonoscopy.As GI physicians, we know that colonoscopy saves lives – it is the only test that screens, detects and prevents colorectal cancer. The most important takeaway from the study is that CRC screening is effective when it is performed. The NordICC trial data show that when people did get colonoscopy, it reduced the risk for CRC by 31% and cut the risk for dying from CRC by 50%.TheRead More

Generated by Feedzy